Randomised Trial of Two Different Daily Doses of Interferon- versus Classical Therapy in Treatment-Naïve Patients with Chronic Hepatitis C

Author： Montalto G.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.9, 2002-01, pp. : 623-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 977-980

Bentham Science Publishers

Access to resources Recommend Favorite

Which is the Most Cost-Effective Combination Therapy Strategy Using Interferon -2b plus Ribavirin for Naïve Patients with Chronic Hepatitis C?

By Buti M.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Daily Interferon Regimen for Chronic Hepatitis C: A Prospective Randomised Study

By Bruno R.  

Clinical Drug Investigation, Vol. 18, Iss. 1, 1999-07 ,pp. : 11-16

Adis International

Access to resources Recommend Favorite

Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients

By Röshammar Daniel  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 6, 2011-12 ,pp. : 727-742

Springer Publishing Company

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite